Skip to content

This website is a third-party information service. It does not provide medical care or operate a treatment facility.

Cancer Surgery Trials

Rochester, Minnesota

Cancer surgery and procedure trials in Rochester, MN

58 cancer surgery and procedure studies are recruiting participants at sites in Rochester as of November 18, 2026, according to ClinicalTrials.gov. Cancer Surgery Trials can help you understand your options and connect with a study team.

Call (888) 350-9284
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Rochester at a glance

  • 58 studies are recruiting at a site in Rochester.
  • By phase: Phase 1 (7), Phase 1/2 (2), Phase 2 (19), Phase 2/3 (1), Phase 3 (14), No phase (9), Observational (6). Studies of devices and behavioral approaches have no phase.
  • By sponsor: university, hospital or other (47), government (9), industry (2).
  • By research area: Lymphoma (18), Breast Cancer (15), Lung Cancer (9), Prostate Cancer (7), Pancreatic Cancer (6), Melanoma (3).
  • Most recent update to one of these records: November 18, 2026.

Breast cancer studies recruiting in Rochester

Basic details from each study's public record (the 30 most recently updated of 58). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

    • Phase 2
    • All ages
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Study site
    Mayo Clinic in Rochester
    Registry record
    NCT05564377 · updated
  2. The LYMPH Trial - Microsurgical Versus Conservative Treatment of Chronic Breast Cancer Associated Lymphedema

    • No phase
    • Ages 18 and older
    • All sexes
    Sponsor
    University Hospital, Basel, Switzerland
    Study site
    Mayo Clinic
    Registry record
    NCT05890677 · updated
  3. Molecular Breast Imaging Guidance for Breast Biopsy for Patients With Breast Abnormalities

    • No phase
    • Ages 18 and older
    • Female participants
    Sponsor
    Mayo Clinic
    Study site
    Mayo Clinic in Rochester
    Registry record
    NCT06058650 · updated
  4. ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Alliance for Clinical Trials in Oncology
    Study site
    Mayo Clinic in Rochester
    Registry record
    NCT06876714 · updated
  5. Low Dose Aspirin for the Prevention of Postpartum Related Breast Cancer

    • Phase 2
    • Ages 18 to 45
    • Female participants
    Sponsor
    Mayo Clinic
    Study site
    Mayo Clinic in Rochester
    Registry record
    NCT05557877 · updated
  6. Evaluation of Alternative Site Goserelin Acetate Injection for Ovarian Function Suppression (OFS) in Local and Locally Advanced Premenopausal Hormone Receptor Positive Breast Cancer Patients

    • Phase 2
    • Ages 18 to 50
    • Female participants
    Sponsor
    Mayo Clinic
    Study site
    Mayo Clinic in Rochester
    Registry record
    NCT07460752 · updated
  7. An Optimized Ultrasound Twinkling Marker for the Imaging of Lymph Nodes in Patients With Clinically Node-Positive Breast Cancer, The UTMOST2 Trial

    • Phase 1
    • Ages 18 and older
    • Female participants
    Sponsor
    Mayo Clinic
    Study site
    Mayo Clinic in Rochester
    Registry record
    NCT06999798 · updated

Source: ClinicalTrials.gov. Data processed . See every breast cancer study recruiting in Rochester, MN on ClinicalTrials.gov.

Lung cancer studies recruiting in Rochester

  1. Testing Lutetium Lu 177 Dotatate in Patients With Somatostatin Receptor Positive Advanced Bronchial Neuroendocrine Tumors

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Study site
    Mayo Clinic in Rochester
    Registry record
    NCT04665739 · updated
  2. Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Study site
    Mayo Clinic in Rochester
    Registry record
    NCT04267848 · updated
  3. Cemiplimab and Fianlimab Before Surgery for the Treatment of Stage IB-IIIB Non-Small Cell Lung Cancer

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Mayo Clinic
    Study site
    Mayo Clinic in Rochester
    Registry record
    NCT06918132 · updated
  4. Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    SWOG Cancer Research Network
    Study site
    Mayo Clinic in Rochester
    Registry record
    NCT06116682 · updated
  5. Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

    • Phase 2/3
    • Ages 18 and older
    • All sexes
    Sponsor
    SWOG Cancer Research Network
    Study site
    Mayo Clinic in Rochester
    Registry record
    NCT06616584 · updated

Source: ClinicalTrials.gov. Data processed . See every lung cancer study recruiting in Rochester, MN on ClinicalTrials.gov.

Prostate cancer studies recruiting in Rochester

  1. Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Study site
    Mayo Clinic in Rochester
    Registry record
    NCT03866382 · updated
  2. Adaptive Radiation Therapy (ART) Stereotactic Ablative Body Radiotherapy (SABR) for Primary Localized Prostate Cancer

    • No phase
    • Ages 18 and older
    • Male participants
    Sponsor
    Mayo Clinic
    Study site
    Mayo Clinic in Rochester
    Registry record
    NCT06325046 · updated
  3. Study of PSMA-targeted Therapy and Androgen Receptor Suppression in Low-volume Metastatic ProstatE Cancer: SPARKLE Trial

    • Phase 2
    • Ages 18 and older
    • Male participants
    Sponsor
    Mayo Clinic
    Study site
    Mayo Clinic in Rochester
    Registry record
    NCT07650240 · updated

Source: ClinicalTrials.gov. Data processed . See every prostate cancer study recruiting in Rochester, MN on ClinicalTrials.gov.

Melanoma studies recruiting in Rochester

  1. BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Study site
    Mayo Clinic in Rochester
    Registry record
    NCT05136196 · updated

Source: ClinicalTrials.gov. Data processed . See every melanoma study recruiting in Rochester, MN on ClinicalTrials.gov.

Lymphoma studies recruiting in Rochester

  1. Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular Lymphoma

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Study site
    Mayo Clinic in Rochester
    Registry record
    NCT06337318 · updated
  2. The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

    • Phase 1/2
    • Up to age 22
    • All sexes
    Sponsor
    PedAL BCU, LLC
    Study site
    Mayo Clinic in Rochester
    Registry record
    NCT04726241 · updated
  3. Testing Whether High Dose Chemotherapy and Infusion of the Patients' Own Stem Cells Improves Survival in Patients With Peripheral T-cell Lymphoma Who Achieved a Complete Response at the End of the Initial Chemotherapy

    • Phase 3
    • Ages 18 to 75
    • All sexes
    Sponsor
    Eastern Cooperative Oncology Group
    Study site
    Mayo Clinic in Rochester
    Registry record
    NCT06724237 · updated
  4. Testing the Combination of Venetoclax and Rituximab, in Comparison to the Usual Treatment (Ibrutinib Plus Rituximab or Zanubrutinib Alone) for Waldenstrom's Macroglobulinemia/Lymphoplasmacytic Lymphoma

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Study site
    Mayo Clinic in Rochester
    Registry record
    NCT04840602 · updated
  5. A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab

    • Phase 3
    • Ages 5 to 60
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Study site
    Mayo Clinic in Rochester
    Registry record
    NCT05675410 · updated
  6. Reduced Dose Radiotherapy for the Treatment of Indolent Non-Hodgkin Lymphoma

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Mayo Clinic
    Study site
    Mayo Clinic in Rochester
    Registry record
    NCT06386315 · updated
  7. Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia

    • Phase 3
    • Ages 18 to 39
    • All sexes
    Sponsor
    Alliance for Clinical Trials in Oncology
    Study site
    Mayo Clinic in Rochester
    Registry record
    NCT03150693 · updated
  8. Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL

    • Phase 3
    • Ages 65 and older
    • All sexes
    Sponsor
    Alliance for Clinical Trials in Oncology
    Study site
    Mayo Clinic in Rochester
    Registry record
    NCT07321652 · updated
  9. A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

    • Phase 2
    • From 366 days, up to 46 years
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Study site
    Mayo Clinic in Rochester
    Registry record
    NCT06124157 · updated
  10. Golcadomide and Rituximab as Bridging Therapy for Relapsed or Refractory Aggressive B-cell Non-Hodgkin Lymphoma Before CAR T-cell Therapy

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Mayo Clinic
    Study site
    Mayo Clinic in Rochester
    Registry record
    NCT06834373 · updated
  11. Ascorbic Acid and Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma, CCUS, and Chronic Myelomonocytic Leukemia

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Mayo Clinic
    Study site
    Mayo Clinic in Rochester
    Registry record
    NCT03418038 · updated

Source: ClinicalTrials.gov. Data processed . See every lymphoma study recruiting in Rochester, MN on ClinicalTrials.gov.

Pancreatic cancer studies recruiting in Rochester

  1. A Screening Program to Improve the Early Detection of Sporadic Pancreatic Cancer in Individuals With a High-Risk of Developing Pancreatic Cancer

    • No phase
    • Ages 50 to 85
    • All sexes
    Sponsor
    Mayo Clinic
    Study site
    Mayo Clinic in Rochester
    Registry record
    NCT07324096 · updated
  2. BMS-986340 in Combination With Nivolumab, Gemcitabine and Nab-paclitaxel for the Treatment of Metastatic and Recurrent Pancreatic Adenocarcinoma

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Mayo Clinic
    Study site
    Mayo Clinic in Rochester
    Registry record
    NCT07226856 · updated
  3. Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers

    • Observational
    • Ages 50 to 75
    • All sexes
    Sponsor
    ECOG-ACRIN Cancer Research Group
    Study site
    Mayo Clinic in Rochester
    Registry record
    NCT04239573 · updated

Source: ClinicalTrials.gov. Data processed . See every pancreatic cancer study recruiting in Rochester, MN on ClinicalTrials.gov.

Ask about studies near Rochester

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

More locations in Minnesota

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 18, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that test a surgery or another procedure, as each study is coded in the registry.

Cancer Surgery Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 350-9284

or send a short form

How should we reach you?

Call